Sinco Pharmaceuticals Holdings Limited

SEHK:6833 株式レポート

時価総額:HK$498.1m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Sinco Pharmaceuticals Holdings バランスシートの健全性

財務の健全性 基準チェック /66

Sinco Pharmaceuticals Holdingsの総株主資本はCN¥628.1M 、総負債はCN¥241.7Mで、負債比率は38.5%となります。総資産と総負債はそれぞれCN¥1.9BとCN¥1.3Bです。 Sinco Pharmaceuticals Holdingsの EBIT はCN¥116.5Mで、利息カバレッジ比率30.3です。現金および短期投資はCN¥437.9Mです。

主要情報

38.5%

負債資本比率

CN¥241.74m

負債

インタレスト・カバレッジ・レシオ30.3x
現金CN¥437.92m
エクイティCN¥628.05m
負債合計CN¥1.26b
総資産CN¥1.89b

財務の健全性に関する最新情報

Recent updates

Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings

Apr 02
Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings

Sinco Pharmaceuticals Holdings Limited (HKG:6833) Might Not Be As Mispriced As It Looks

Mar 08
Sinco Pharmaceuticals Holdings Limited (HKG:6833) Might Not Be As Mispriced As It Looks

Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

Nov 07
Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

A Look At The Intrinsic Value Of Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Jun 26
A Look At The Intrinsic Value Of Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

May 30
Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet

Oct 26
Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet

Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Might Deserve Your Attention Today

Feb 04
Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Might Deserve Your Attention Today

I Ran A Stock Scan For Earnings Growth And Sinco Pharmaceuticals Holdings (HKG:6833) Passed With Ease

Oct 25
I Ran A Stock Scan For Earnings Growth And Sinco Pharmaceuticals Holdings (HKG:6833) Passed With Ease

Little Excitement Around Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Earnings

Jun 10
Little Excitement Around Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Earnings

Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt

May 24
Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt

Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Is An Interesting Stock

Apr 20
Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Is An Interesting Stock

We're Not So Sure You Should Rely on Sinco Pharmaceuticals Holdings' (HKG:6833) Statutory Earnings

Feb 16
We're Not So Sure You Should Rely on Sinco Pharmaceuticals Holdings' (HKG:6833) Statutory Earnings

How Much Did Sinco Pharmaceuticals Holdings'(HKG:6833) Shareholders Earn From Share Price Movements Over The Last Three Years?

Jan 11
How Much Did Sinco Pharmaceuticals Holdings'(HKG:6833) Shareholders Earn From Share Price Movements Over The Last Three Years?

Should You Be Excited About Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 51% Return On Equity?

Dec 07
Should You Be Excited About Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 51% Return On Equity?

財務状況分析

短期負債: 6833の 短期資産 ( CN¥1.4B ) が 短期負債 ( CN¥1.2B ) を超えています。

長期負債: 6833の短期資産 ( CN¥1.4B ) が 長期負債 ( CN¥30.6M ) を上回っています。


デット・ツー・エクイティの歴史と分析

負債レベル: 6833総負債よりも多くの現金を保有しています。

負債の削減: 6833の負債対資本比率は、過去 5 年間で638.1%から38.5%に減少しました。

債務返済能力: 6833の負債は 営業キャッシュフロー によって 十分にカバー されています ( 146.3% )。

インタレストカバレッジ: 6833の負債に対する 利息支払いEBIT ( 30.3 x coverage) によって 十分にカバーされています


貸借対照表


健全な企業の発掘